Enterin is the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease



Convertible Note




Org chart

David Mccullough
CEO & Board Member
Denise Barbut
Co-Founder, Chief Medical Officer & Board Member
Michael Zasloff
Co-Founder, Chief Scientific Officer & Board Member
William Kinney
Co-Founder & SVP of R&D
Hilde Williams
Senior Regulatory Advisor, Regulatory Strategy & Operations
Christina Gallagher
Clinical Trials Logistics Manager
Constantine Ward
Global Head of Clinical Trial Supply
Denise Barbut MD FRCP
Co-Founder, President and CMO
D. Phillip Cox
VP Commercial Manufacturing
Felisha B.
Study start-up Lead/ QC reviewer (remote)
Jennifer Beezley
Associate Director, Clinical Trial Management
Kimberly Man, MBA, PMP
Vice President Operations
Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.